HIV TREATMENT
2020
Pharmaceutical companies, SRAs, WHO Prequalification Programme (PQ) and NRAs commit to:
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Action 14
Committed by:
Include adolescents when conducting initial adult efficacy trials, where possible and practical, or conduct parallel trials with the goal of providing information to support licencing for adolescents at the same time as adults.
Pharmaceutical companies
Sub-Actions & Milestones
Sub-action 14.1
Include adolescents when conducting initial adult efficacy trials or conduct parallel trials with the goal of providing information to support licencing for adolescents at the same time as adults.
Pharmaceutical companies
-
-
Milestone 14.1.1
-
-
-
-
Document (s)
-
-
-
-
Updates
Notes
Responsible